Published in J Infect Dis on February 01, 2000
An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med (2002) 2.25
OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine. Clin Vaccine Immunol (2007) 0.97
Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science (1990) 7.33
Structural basis for the binding of proline-rich peptides to SH3 domains. Cell (1994) 6.34
Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature (1998) 6.32
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med (1996) 5.46
The complex and intriguing lives of PIP2 with ion channels and transporters. Sci STKE (2001) 4.45
Borrelia burgdorferi genes selectively expressed in the infected host. Proc Natl Acad Sci U S A (1995) 3.42
Patient, center and geographic characteristics of nationally placed livers. Am J Transplant (2012) 3.16
Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect Immun (1992) 3.04
Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A (1992) 2.99
Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J Infect Dis (1994) 2.72
Paternal population history of East Asia: sources, patterns, and microevolutionary processes. Am J Hum Genet (2001) 2.71
A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant (2010) 2.69
Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am J Trop Med Hyg (1992) 2.57
Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. J Immunol (1992) 2.49
The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant (2008) 2.48
Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice. Infect Immun (1994) 2.42
Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. Immunity (1997) 2.38
Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J Infect Dis (1991) 2.37
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host. J Clin Invest (1997) 2.13
Transmissible murine colonic hyperplasia. Vet Pathol (1978) 2.11
The ultrastructure of transmissible murine colonic hyperplasia. Am J Pathol (1979) 2.11
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis (1994) 2.09
The etiology of transmissible murine colonic hyperplasia. Lab Anim Sci (1976) 1.98
Detection of Borrelia burgdorferi infection in Ixodes dammini ticks with the polymerase chain reaction. J Clin Microbiol (1990) 1.96
Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature (1997) 1.95
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B. Proc Natl Acad Sci U S A (1993) 1.84
Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology (1997) 1.83
Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice. Infect Immun (1998) 1.80
Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am J Trop Med Hyg (1990) 1.77
Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol (2000) 1.76
Long-term protection of mice from Lyme disease by vaccination with OspA. Infect Immun (1992) 1.75
Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis (1997) 1.74
Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun (1994) 1.71
Serum-mediated resolution of Lyme arthritis in mice. Lab Invest (1996) 1.68
The early humoral response in human granulocytic ehrlichiosis. J Infect Dis (1997) 1.67
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol (1998) 1.64
Arthropod- and host-specific Borrelia burgdorferi bbk32 expression and the inhibition of spirochete transmission. J Immunol (2000) 1.63
Infectious but nonpathogenic isolate of Borrelia burgdorferi. J Clin Microbiol (1990) 1.63
Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant (2014) 1.62
T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun (2000) 1.60
Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab Anim Sci (1977) 1.60
Experimental chronic Lyme borreliosis in Lewis rats. Am J Trop Med Hyg (1990) 1.59
Expression and gene sequence of outer surface protein C of Borrelia burgdorferi reisolated from chronically infected mice. Infect Immun (1994) 1.57
Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest (1997) 1.56
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia. Am J Transplant (2011) 1.54
Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity. Infect Immun (2000) 1.53
Immune evasion by tickborne and host-adapted Borrelia burgdorferi. J Infect Dis (1998) 1.52
T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun (1997) 1.51
Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies. Lab Anim Sci (1998) 1.51
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50
Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant (2012) 1.50
Borrelia burgdorferi erpT expression in the arthropod vector and murine host. Mol Microbiol (1999) 1.50
Delta 9-tetrahydrocannabivarin (delta 9-THCV) as a marker for the ingestion of cannabis versus Marinol. J Anal Toxicol (1999) 1.43
Phosphatidylinositol 4,5-bisphosphate induces actin stress-fiber formation and inhibits membrane ruffling in CV1 cells. J Cell Biol (2001) 1.43
Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J Clin Invest (1996) 1.42
Negative words on surgical wards result in therapeutic failure of patient-controlled analgesia and further release of cortisol after abdominal surgeries. Minerva Anestesiol (2008) 1.41
The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. Infect Immun (2000) 1.41
Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo. J Infect Dis (1991) 1.40
Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res (1977) 1.40
Effect of 24-h blood pressure levels and circadian blood pressure rhythm on left ventricular structure and function in isolated systolic hypertension. Int J Cardiol (1994) 1.39
A procedure to overcome interferences caused by the adulterant "Klear" in the GC-MS analysis of 11-nor-delta9-THC-9-COOH. J Anal Toxicol (1997) 1.39
OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect Immun (1993) 1.39
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation (2001) 1.38
Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis (1998) 1.37
The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci (1993) 1.37
Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast. J Org Chem (2001) 1.37
Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein. Infect Immun (2000) 1.36
Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required. Proc Natl Acad Sci U S A (1991) 1.36
Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury. Am J Transplant (2007) 1.36
Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo. Mol Med (1997) 1.35
Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans. J Clin Microbiol (1996) 1.31
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage (2012) 1.30
Expression and sequence of outer surface protein C among North American isolates of Borrelia burgdorferi. FEMS Microbiol Lett (1994) 1.29
Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol Cell Biol (1995) 1.26
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun (2001) 1.26
Mouse hepatitis virus strain--related patterns of tissue tropism in suckling mice. Arch Virol (1984) 1.25
Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines. J Exp Med (1993) 1.23
Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant (2007) 1.22
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res (1998) 1.19
The putative E5 open reading frame of cottontail rabbit papillomavirus is dispensable for papilloma formation in domestic rabbits. J Virol (1992) 1.18
Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. J Infect Dis (1998) 1.17
CD4+ T helper 1 cells facilitate regression of murine Lyme carditis. Infect Immun (2001) 1.17
Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse. Infect Immun (1993) 1.17
Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol (2000) 1.16
Interaction of PIP(2) with the XIP region of the cardiac Na/Ca exchanger. Am J Physiol Cell Physiol (2000) 1.15
Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J Infect Dis (1991) 1.14
Association of bone scintigraphic abnormalities with knee malalignment and pain. Ann Rheum Dis (2008) 1.14
[Clinical treatment of hepatic and abdominal hydatid cyst by percutaneous puncture, drainage and curettage]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (1994) 1.12
Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice. Antimicrob Agents Chemother (1994) 1.11
Spontaneous wasting disease in nude mice associated with Pneumocystis carinii infection. Lab Anim Sci (1986) 1.11
Protective antibodies in murine Lyme disease arise independently of CD40 ligand. J Immunol (1996) 1.10
Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J Immunol (1997) 1.09
Rapid eye movement sleep deprivation selectively impairs recall of fear extinction in hippocampus-independent tasks in rats. Neuroscience (2006) 1.08